Annual Net Income
-$322.30 M
-$110.08 M-51.87%
December 31, 2024
Summary
- As of March 13, 2025, RNA annual net profit is -$322.30 million, with the most recent change of -$110.08 million (-51.87%) on December 31, 2024.
- During the last 3 years, RNA annual net income has fallen by -$204.29 million (-173.12%).
- RNA annual net income is now -2773.59% below its all-time high of -$11.22 million, reached on December 31, 2018.
Performance
RNA Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$102.26 M
-$21.86 M-27.19%
December 31, 2024
Summary
- As of March 13, 2025, RNA quarterly net profit is -$102.26 million, with the most recent change of -$21.86 million (-27.19%) on December 31, 2024.
- Over the past year, RNA quarterly net income has dropped by -$21.86 million (-27.19%).
- RNA quarterly net income is now -3911.65% below its all-time high of -$2.55 million, reached on March 31, 2019.
Performance
RNA Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$322.30 M
-$41.81 M-14.91%
December 31, 2024
Summary
- As of March 13, 2025, RNA TTM net profit is -$322.30 million, with the most recent change of -$41.81 million (-14.91%) on December 31, 2024.
- Over the past year, RNA TTM net income has dropped by -$41.81 million (-14.91%).
- RNA TTM net income is now -12544.29% below its all-time high of -$2.55 million, reached on March 31, 2019.
Performance
RNA TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
RNA Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -51.9% | -27.2% | -14.9% |
| 3 y3 years | -173.1% | -27.2% | -14.9% |
| 5 y5 years | -1203.1% | -27.2% | -14.9% |
RNA Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -173.1% | at low | -198.7% | at low | -173.1% | at low |
| 5 y | 5-year | -1203.1% | at low | -1580.5% | at low | -1203.1% | at low |
| alltime | all time | -2773.6% | at low | -3911.7% | at low | <-9999.0% | at low |
Avidity Biosciences Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$322.30 M(+51.9%) | -$102.26 M(+27.2%) | -$322.30 M(+14.9%) |
| Sep 2024 | - | -$80.40 M(+13.6%) | -$280.49 M(+11.1%) |
| Jun 2024 | - | -$70.79 M(+2.8%) | -$252.45 M(+10.4%) |
| Mar 2024 | - | -$68.86 M(+13.9%) | -$228.68 M(+7.8%) |
| Dec 2023 | -$212.22 M(+22.0%) | -$60.44 M(+15.4%) | -$212.22 M(+4.9%) |
| Sep 2023 | - | -$52.36 M(+11.3%) | -$202.25 M(+4.5%) |
| Jun 2023 | - | -$47.02 M(-10.2%) | -$193.49 M(+0.7%) |
| Mar 2023 | - | -$52.39 M(+3.8%) | -$192.15 M(+10.4%) |
| Dec 2022 | -$174.00 M(+47.4%) | -$50.47 M(+15.8%) | -$174.00 M(+7.4%) |
| Sep 2022 | - | -$43.60 M(-4.6%) | -$162.06 M(+9.7%) |
| Jun 2022 | - | -$45.69 M(+33.5%) | -$147.74 M(+15.1%) |
| Mar 2022 | - | -$34.23 M(-11.2%) | -$128.40 M(+8.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$118.01 M(+166.1%) | -$38.54 M(+31.6%) | -$118.01 M(+23.3%) |
| Sep 2021 | - | -$29.27 M(+11.1%) | -$95.75 M(+22.9%) |
| Jun 2021 | - | -$26.35 M(+10.5%) | -$77.91 M(+25.4%) |
| Mar 2021 | - | -$23.84 M(+46.5%) | -$62.11 M(+40.0%) |
| Dec 2020 | -$44.35 M(+79.3%) | -$16.27 M(+42.3%) | -$44.35 M(+15.3%) |
| Sep 2020 | - | -$11.44 M(+8.4%) | -$38.48 M(+14.2%) |
| Jun 2020 | - | -$10.56 M(+73.5%) | -$33.71 M(+19.2%) |
| Mar 2020 | - | -$6.08 M(-41.5%) | -$28.27 M(+14.3%) |
| Dec 2019 | -$24.73 M(+120.5%) | -$10.40 M(+56.0%) | -$24.73 M(+72.6%) |
| Sep 2019 | - | -$6.67 M(+30.3%) | -$14.33 M(+87.0%) |
| Jun 2019 | - | -$5.12 M(+100.7%) | -$7.67 M(+200.7%) |
| Mar 2019 | - | -$2.55 M | -$2.55 M |
| Dec 2018 | -$11.22 M | - | - |
FAQ
- What is Avidity Biosciences annual net profit?
- What is the all time high annual net income for Avidity Biosciences?
- What is Avidity Biosciences annual net income year-on-year change?
- What is Avidity Biosciences quarterly net profit?
- What is the all time high quarterly net income for Avidity Biosciences?
- What is Avidity Biosciences quarterly net income year-on-year change?
- What is Avidity Biosciences TTM net profit?
- What is the all time high TTM net income for Avidity Biosciences?
- What is Avidity Biosciences TTM net income year-on-year change?
What is Avidity Biosciences annual net profit?
The current annual net income of RNA is -$322.30 M
What is the all time high annual net income for Avidity Biosciences?
Avidity Biosciences all-time high annual net profit is -$11.22 M
What is Avidity Biosciences annual net income year-on-year change?
Over the past year, RNA annual net profit has changed by -$110.08 M (-51.87%)
What is Avidity Biosciences quarterly net profit?
The current quarterly net income of RNA is -$102.26 M
What is the all time high quarterly net income for Avidity Biosciences?
Avidity Biosciences all-time high quarterly net profit is -$2.55 M
What is Avidity Biosciences quarterly net income year-on-year change?
Over the past year, RNA quarterly net profit has changed by -$21.86 M (-27.19%)
What is Avidity Biosciences TTM net profit?
The current TTM net income of RNA is -$322.30 M
What is the all time high TTM net income for Avidity Biosciences?
Avidity Biosciences all-time high TTM net profit is -$2.55 M
What is Avidity Biosciences TTM net income year-on-year change?
Over the past year, RNA TTM net profit has changed by -$41.81 M (-14.91%)